Immunoglobulin News and Research

RSS
Can a single BNT162b2 vaccine dose confer protective immunity against SARS-CoV-2 variants?

Can a single BNT162b2 vaccine dose confer protective immunity against SARS-CoV-2 variants?

Characterization of lab-produced neutralizing antibodies targeting SARS-CoV-2

Characterization of lab-produced neutralizing antibodies targeting SARS-CoV-2

Seroprevalence studies monitoring SARS-CoV-2 among vaccinees require more than spike assays

Seroprevalence studies monitoring SARS-CoV-2 among vaccinees require more than spike assays

Can fingerprick blood tests help evaluate antibody response and longevity against SARS-CoV-2 post-vaccination?

Can fingerprick blood tests help evaluate antibody response and longevity against SARS-CoV-2 post-vaccination?

One dose of mRNA vaccine may be sufficient for individuals previously infected with SARS-CoV-2

One dose of mRNA vaccine may be sufficient for individuals previously infected with SARS-CoV-2

Novel mRNA delivery vehicle provides alternative to LNPs for SARS-CoV-2 vaccines

Novel mRNA delivery vehicle provides alternative to LNPs for SARS-CoV-2 vaccines

COVID-19 vaccination of lactating mothers elicits specific IgA antibodies in breast milk

COVID-19 vaccination of lactating mothers elicits specific IgA antibodies in breast milk

COVID-19 vaccine INO-4800 shows efficacy against SARS-CoV-2 variants

COVID-19 vaccine INO-4800 shows efficacy against SARS-CoV-2 variants

Evidence of sustained immune responses weeks after Pfizer-BioNTech BNT162b2 vaccination

Evidence of sustained immune responses weeks after Pfizer-BioNTech BNT162b2 vaccination

A new polymersome-based SARS-CoV-2 nanovaccine elicits robust immunity

A new polymersome-based SARS-CoV-2 nanovaccine elicits robust immunity

Measurable antibody response to mRNA COVID-19 vaccine in elderly care home residents

Measurable antibody response to mRNA COVID-19 vaccine in elderly care home residents

SARS-CoV-2 spike E484K mutation reduces antibody neutralization

SARS-CoV-2 spike E484K mutation reduces antibody neutralization

Commercial assays detect mRNA-1273 and BNT162b2 vaccine-induced SARS-CoV-2 antibodies in most vaccinated participants

Commercial assays detect mRNA-1273 and BNT162b2 vaccine-induced SARS-CoV-2 antibodies in most vaccinated participants

Serum and breast milk SARS-CoV-2 antibodies correlated in vaccinated mothers

Serum and breast milk SARS-CoV-2 antibodies correlated in vaccinated mothers

Prefusion SARS-CoV-2 spike-based vaccine candidate shows high safety and efficacy in phase I trial

Prefusion SARS-CoV-2 spike-based vaccine candidate shows high safety and efficacy in phase I trial

Mouse monoclonal antibodies protect against SARS-CoV-2 wildtype, UK and South African variants

Mouse monoclonal antibodies protect against SARS-CoV-2 wildtype, UK and South African variants

Bispecific antibodies neutralize SARS-CoV-2 and its variants

Bispecific antibodies neutralize SARS-CoV-2 and its variants

CoVIg-19 Plasma Alliance announces outcomes of NIH-funded Phase 3 ITAC clinical trial

CoVIg-19 Plasma Alliance announces outcomes of NIH-funded Phase 3 ITAC clinical trial

70% of SARS-CoV-2 infected in Wuhan still have IgG antibodies

70% of SARS-CoV-2 infected in Wuhan still have IgG antibodies

Study suggests T-cells don't determine survival in severe COVID-19

Study suggests T-cells don't determine survival in severe COVID-19